09.03.2013 Views

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Index<br />

NF-kB Activation <strong>Inhibitor</strong> II, JSH-23 ......................... 56<br />

NGIC-I ......................................................................................39<br />

Niflumic Acid ...................................................................87, 97<br />

L-NIL, Dihydrochloride .......................................................<br />

NIPP- , His•Tag ® , Bovine Thymus,<br />

Recombinant, E. coli .......................................................60<br />

Nitric Oxide Assay Kit, Colorimetric .............................. 2<br />

Nitric Oxide Assay Kit, Fluorometric .............................. 2<br />

Nitric Oxide Synthase Assay Kit ...................................... 2<br />

Nitric Oxide Synthase Assay Kit, Colorimetric ............ 2<br />

Nitric Oxide Synthase, Inducible, <strong>Inhibitor</strong> Set .......... 2<br />

p-Nitroblue Tetrazolium Chloride...................................<br />

7-Nitroindazole ...................................................................<br />

7-Nitroindazole, 3-Bromo-, Sodium Salt .....................<br />

7-Nitroindazole, Sodium Salt ..........................................<br />

N G -Nitro-L-arginine ...........................................................<br />

N G -Nitro-L-arginine Methyl Ester, Hydrochloride .....<br />

5-Nitro-2-(3-phenylpropyl-amino)benzoic Acid .........87<br />

NLVS ....................................................................................... 37<br />

nNOS <strong>Inhibitor</strong> I...................................................................<br />

NOS <strong>Inhibitor</strong> Set ................................................................ 2<br />

Novobiocin, Sodium Salt .....................................................72<br />

NP-LLL-VS ............................................................................ 37<br />

NPPB ..................................................................................23, 26<br />

NS-398 .....................................................................................87<br />

NS 2028 ................................................................................ 06<br />

N-SMase <strong>Inhibitor</strong>, GW4869 .............................................93<br />

NU 025 ....................................................................................79<br />

O<br />

ODQ ........................................................................................ 06<br />

Okadaic Acid, Ammonium Salt ..........................................60<br />

Okadaic Acid, Potassium Salt ............................................6<br />

Okadaic Acid, Prorocentrum concavum ..........................60<br />

InSolution Okadaic Acid,<br />

Prorocentrum concavum ...............................................60<br />

Okadaic Acid, Sodium Salt .................................................6<br />

Oligomycin .................................................................. 43, 5<br />

Olomoucine ............................................................................. 7<br />

InSolution Olomoucine ..................................................... 7<br />

Olomoucine II ......................................................................... 7<br />

Olomoucine, Iso- ................................................................... 7<br />

Olomoucine, N 9 -Isopropyl- ................................................. 7<br />

InSolution OM99-2 ......................................................... 0<br />

Omeprazole .......................................................................... 43<br />

Omi/HtrA2 Protease <strong>Inhibitor</strong>, Ucf- 0 ..........................67<br />

Oridonin, R. rubescens ...................................................... 56<br />

Ouabain, Octahydrate ....................................................... 43<br />

Oxamflatin ..............................................................................74<br />

Oxindole I ................................................................................5<br />

P<br />

p38 MAP Kinase <strong>Inhibitor</strong> ...................................................26<br />

p38 MAP Kinase <strong>Inhibitor</strong> III ..............................................26<br />

InSolution p38 MAP Kinase <strong>Inhibitor</strong> III ...............26, 84<br />

p-APMSF, Hydrochloride .................................................. 26<br />

PACOCF 3 ...................................................................................94<br />

PARP Cleavage Detection Kit .............................................79<br />

PARP <strong>Inhibitor</strong> Set ................................................................79<br />

Parthenolide, Tanacetum parthenium .......................... 56<br />

,3-PBITU, Dihydrobromide ..............................................<br />

PD 98059 .................................................................................26<br />

PD 45305 ............................................................................ 6<br />

PD 50606 ............................................................................ 6<br />

PD 5 746 ............................................................................. 6<br />

PD 53035 ..............................................................................5<br />

InSolution PD 53035 ......................................................5<br />

PD 56273 ..............................................................................5<br />

PD 58780 ..............................................................................5<br />

InSolution PD 58780 ......................................................84<br />

PD 68393 ..............................................................................5<br />

PD 693 6 ...............................................................................26<br />

PD 74265 ..............................................................................5<br />

PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> I ....................5<br />

PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> II ...................5<br />

PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> III ..................5<br />

DL-threo-PDMP, Hydrochloride...................................... 48<br />

a -PDX, Human, Recombinant, E. coli ......................... 30<br />

Pentoxifylline ..........................................................................70<br />

Pepstatin A Methyl Ester .................................................. 0<br />

Pepstatin A, Synthetic....................................................... 30<br />

Pfmrk <strong>Inhibitor</strong>, WR 2 6 74 .............................................. 7<br />

Phenylarsine Oxide ...............................................................6<br />

Phenylmethylsulfonyl Fluoride ...................................... 30<br />

Phloretin ..................................................................................39<br />

PHM-L LIPOSORB Absorbent ..........................................90<br />

Phorbol- 2, 3-dibutyrate ............................................... 43<br />

Phosphatase <strong>Inhibitor</strong> Cocktail Set I ...............................62<br />

Phosphatase <strong>Inhibitor</strong> Cocktail Set II ..............................62<br />

Phosphatase <strong>Inhibitor</strong> Cocktail Set III .............................62<br />

Phosphatase <strong>Inhibitor</strong> Cocktail Set IV .............................62<br />

5-Phosphatase <strong>Inhibitor</strong> .....................................................6<br />

Phosphodiesterase 4 <strong>Inhibitor</strong> ........................................ 58<br />

Phosphodiesterase <strong>Inhibitor</strong> Set I .................................. 58<br />

Phosphodiesterase V <strong>Inhibitor</strong> II .................................... 58<br />

Phosphoramidon, Disodium Salt .................................... 30<br />

Phosphotyrosine Phosphatase <strong>Inhibitor</strong> Set<br />

(Vanadium) .......................................................................62<br />

PI 3-Kg <strong>Inhibitor</strong> ....................................................................3<br />

PI 3-Kg <strong>Inhibitor</strong> II ................................................................32<br />

Piceatannol ....................................................... 29, 34, 39, 5<br />

Pifithrin-a ...............................................................................67<br />

Pifithrin-a, Cyclic-................................................................67<br />

PIPER .........................................................................................80<br />

PJ34 ...........................................................................................79<br />

PKC b <strong>Inhibitor</strong> .........................................................................39<br />

PKC bII /EGFR <strong>Inhibitor</strong> ............................................................39<br />

PKC i , GST-Fusion Protein, Active, Human,<br />

Recombinant, S. frugiperda..........................................42<br />

PKC m , GST-Fusion Protein, Active, Human,<br />

Recombinant, S. frugiperda..........................................42<br />

PKC n , GST-Fusion Protein, Active, Human,<br />

Recombinant, S. frugiperda..........................................42<br />

Plasminogen Activator <strong>Inhibitor</strong>- , Human,<br />

Recombinant ................................................................. 59<br />

Plasminogen Activator <strong>Inhibitor</strong>- , Mutant,<br />

Human, Recombinant ................................................. 59<br />

Plasminogen Activator <strong>Inhibitor</strong>- , Mutant,<br />

Mouse, Recombinant .................................................. 59<br />

Plasminogen Activator <strong>Inhibitor</strong>- , Rat,<br />

Recombinant ................................................................. 59<br />

Polymyxin B Sulfate .............................................................39<br />

PP Analog ..............................................................................5<br />

PP Analog II, NM-PP ................................................8, 5<br />

PP2 ............................................................................................5<br />

InSolution PP2 ....................................................................5<br />

PP3 ............................................................................................5<br />

PPACK II, Trifluoroacetate Salt ....................................... 30<br />

PPACK, Dihydrochloride .................................................... 30<br />

PPACK Dihydrochloride, Biotinylated ........................... 30<br />

PPM- 8 ......................................................................... , 56<br />

Pravastatin, Sodium Salt .....................................................89<br />

Prolyl Endopeptidase <strong>Inhibitor</strong> II ................................... 3<br />

N G -Propyl-L-arginine .........................................................<br />

Protease Arrest Reagent ................................................ 34<br />

Protease <strong>Inhibitor</strong> Cocktail Set I .................................... 32<br />

Protease <strong>Inhibitor</strong> Cocktail Set I, Animal-Free .......... 35<br />

Protease <strong>Inhibitor</strong> Cocktail Set II ................................... 32<br />

Protease <strong>Inhibitor</strong> Cocktail Set III ................................. 32<br />

Protease <strong>Inhibitor</strong> Cocktail Set III, Animal-Free ........ 35<br />

Protease <strong>Inhibitor</strong> Cocktail Set IV ................................. 33<br />

Protease <strong>Inhibitor</strong> Cocktail Set V, Animal-Free ......... 35<br />

Protease <strong>Inhibitor</strong> Cocktail Set V, EDTA-Free ............. 33<br />

Protease <strong>Inhibitor</strong> Cocktail Set VI ................................. 33<br />

Protease <strong>Inhibitor</strong> Cocktail Set VII ................................ 34<br />

Protease <strong>Inhibitor</strong> Cocktail Set VIII ............................... 34<br />

Protease <strong>Inhibitor</strong> III, Anthrax Lethal Factor<br />

(Anthrax Lethal Factor Protease <strong>Inhibitor</strong> III) ....... 3<br />

Protease <strong>Inhibitor</strong> Set ....................................................... 34<br />

Proteasome <strong>Inhibitor</strong> I ..................................................... 37<br />

InSolution Proteasome <strong>Inhibitor</strong> I .............................. 38<br />

Proteasome <strong>Inhibitor</strong> II ..................................................... 38<br />

Proteasome <strong>Inhibitor</strong> III ................................................... 38<br />

Proteasome <strong>Inhibitor</strong> IV ................................................... 38<br />

Proteasome <strong>Inhibitor</strong> VII, Antiprotealide ..................... 38<br />

Proteasome <strong>Inhibitor</strong> Set I ............................................... 38<br />

Proteasome <strong>Inhibitor</strong> Set II ............................................. 38<br />

Protein Arginine N-Methyltransferase<br />

<strong>Inhibitor</strong>, AMI- ................................................... 46, 60<br />

Protein Kinase A <strong>Inhibitor</strong> 5-24 ........................................35<br />

Protein Kinase A <strong>Inhibitor</strong> 6-22 Amide...........................35<br />

Protein Kinase A <strong>Inhibitor</strong> 4-22 Amide,<br />

Cell-Permeable, Myristoylated ....................................35<br />

Protein Kinase C <strong>Inhibitor</strong> 20-28,<br />

Cell-Permeable, Myristoylated ....................................39<br />

Protein Kinase C <strong>Inhibitor</strong> Peptide 9-3 ......................39<br />

Protein Kinase C <strong>Inhibitor</strong> Peptide 9-36 ......................39<br />

Protein Kinase C <strong>Inhibitor</strong> Set ...........................................42<br />

Protein Kinase C <strong>Inhibitor</strong>, EGF-R Fragment<br />

65 -658, Myristoylated ................................................39<br />

Protein Kinase C , His•Tag®, Human,<br />

a<br />

Recombinant, S. frugiperda..........................................42<br />

Protein Kinase C , His•Tag®, Human,<br />

bII<br />

Recombinant ....................................................................42<br />

Protein Kinase C , His•Tag®, Human,<br />

d<br />

Recombinant, S. frugiperda..........................................42<br />

Protein Kinase C Translocation <strong>Inhibitor</strong> Peptide .......40<br />

e<br />

Protein Kinase C Translocation <strong>Inhibitor</strong> Peptide,<br />

e<br />

Negative Control .............................................................40<br />

Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong> .................39<br />

z<br />

Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />

z<br />

Myristoylated ...................................................................39<br />

Protein Kinase C , His•Tag®, Human,<br />

x<br />

Recombinant, S. frugiperda..........................................42<br />

Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />

h<br />

Myristoylated ...................................................................39<br />

Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong> .................39<br />

θ<br />

Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />

θ<br />

Myristoylated ...................................................................39<br />

Protein Kinase C , His•Tag®,<br />

θ<br />

Human, Recombinant, S. frugiperda .........................42<br />

Protein Kinase G Ia <strong>Inhibitor</strong>, Cell-Permeable ..............44<br />

Protein Kinase G <strong>Inhibitor</strong> ..................................................44<br />

Protein Kinase <strong>Inhibitor</strong>, DMAP .........................................23<br />

Protein Phosphatase 2A <strong>Inhibitor</strong> I PP2A ,<br />

Human Kidney, Recombinant, E. coli .........................6<br />

Protein Phosphatase 2A <strong>Inhibitor</strong> I 2<br />

70 Orders Phone 800 854 34 7<br />

Calbiochem • <strong>Inhibitor</strong> SourceBook<br />

Fax 800 776 0999<br />

Web www.emdbiosciences.com/calbiochem<br />

PP2A ,<br />

Human, Recombinant, E. coli .......................................6<br />

Protein Phosphatase <strong>Inhibitor</strong> 2, Human,<br />

Recombinant, E. coli .......................................................6<br />

Protein Phosphatase <strong>Inhibitor</strong> 2, Rabbit Muscle,<br />

Recombinant, E. coli .......................................................6<br />

Protein Phosphatase <strong>Inhibitor</strong> Set II ................................62<br />

Protein Synthesis Initiation <strong>Inhibitor</strong>,<br />

NSC 9889 .......................................................... 60, 6<br />

Protein Tyrosine Phosphatase CD45 <strong>Inhibitor</strong>...............6<br />

Protein Tyrosine Phosphatase <strong>Inhibitor</strong> I ........................6<br />

Protein Tyrosine Phosphatase <strong>Inhibitor</strong> II ......................6<br />

Protein Tyrosine Phosphatase <strong>Inhibitor</strong> III .....................6<br />

Protein Tyrosine Phosphatase <strong>Inhibitor</strong> IV .....................6<br />

P-Selectin Antagonist ..........................................................70<br />

Pterostilbene, Pterocarpus marsupium ...........................87<br />

PTP B <strong>Inhibitor</strong> ......................................................................6<br />

Puromycin, Dihydrochloride ............................................ 6<br />

Puromycin, Dihydrochloride, Cell Culture-Tested ..... 6<br />

Purvalanol A ........................................................................... 7<br />

-Pyrrolidinecarbodithioic Acid, Ammonium Salt .....<br />

Q<br />

Quercetin, Dihydrate .....................................................32, 94<br />

Quinacrine, Dihydrochloride .......................................94, 98<br />

InSolution Q-VD-OPh, Non-O-methylated .................65<br />

R<br />

Radicicol, Diheterospora chlamydosporia ...............52, 87<br />

Raf Kinase <strong>Inhibitor</strong> I .........................................................55<br />

InSolution Raf Kinase <strong>Inhibitor</strong> I .................................55<br />

InSolution Rapamycin .......................................................84<br />

InSolution Ratjadone A, Synthetic ................................77<br />

Resveratrol .......................................................................87, 97<br />

RG- 3022 ................................................................................52<br />

Rho-Kinase <strong>Inhibitor</strong> ............................................................56<br />

InSolution Rho Kinase <strong>Inhibitor</strong> ..............................56, 84<br />

Rho-Kinase <strong>Inhibitor</strong> II ........................................................56<br />

Rho-Kinase <strong>Inhibitor</strong> III, Rockout .....................................56<br />

Rho Kinase <strong>Inhibitor</strong> IV ........................................................56<br />

Ribonuclease <strong>Inhibitor</strong>, Human,<br />

Recombinant, E. coli .......................................................77<br />

Ribonuclease <strong>Inhibitor</strong>, Human Placenta .......................77<br />

Rifampicin ...............................................................................72<br />

RK-682, Streptomyces sp. ...................................................6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!